@article {1576542,
	title = {Metabolic glycan labelling for cancer-targeted therapy},
	journal = {Nat Chem},
	volume = {12},
	number = {12},
	year = {2020},
	month = {2020 12},
	pages = {1102-1114},
	abstract = {Metabolic glycoengineering with unnatural sugars provides a powerful tool to label cell membranes with chemical tags for subsequent targeted conjugation of molecular cargos via efficient chemistries. This technology has been widely explored for cancer labelling and targeting. However, as this metabolic labelling process can occur in both cancerous and normal cells, cancer-selective labelling needs to be achieved to develop cancer-targeted therapies. Unnatural sugars can be either rationally designed to enable preferential labelling of cancer cells, or specifically delivered to cancerous tissues. In this Review Article, we will discuss the progress to date in design and delivery of unnatural sugars for metabolic labelling of tumour cells and subsequent development of tumour-targeted therapy. Metabolic cell labelling for cancer immunotherapy will also be discussed. Finally, we will provide a perspective on future directions of metabolic labelling of cancer and immune cells for the development of potent, clinically translatable cancer therapies.},
	keywords = {Animals, Antineoplastic Agents, Azides, Cell Line, Tumor, Cell Membrane, click chemistry, Drug Carriers, Humans, Immunotherapy, Monosaccharides, Neoplasms, Polysaccharides},
	issn = {1755-4349},
	doi = {10.1038/s41557-020-00587-w},
	author = {Wang, Hua and Mooney, David J}
}
